NYSEARCA:BZF

WisdomTree Brazilian Real Strategy Fund Stock Forecast, Price & News

$16.46
0.00 (0.00 %)
(As of 03/14/2019)
Add
Today's Range
$16.33
$16.53
50-Day Range
$16.46
$16.46
52-Week Range
$14.90
$18.71
Volume6,341 shs
Average Volume4,232 shs
Market Capitalization$12.35 million
P/E RatioN/A
Dividend Yield1.19%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BZF News and Ratings via Email

Sign-up to receive the latest news and ratings for WisdomTree Brazilian Real Strategy Fund and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer
Fund NameWT BRAZILIAN REAL STRAT FUND
Tax Classification
SymbolNYSEARCA:BZF
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$14.81 million
Average Daily Volume$5,027.00
Discount/Premium-0.72%

ETF Expenses

Management Fee0.45%
Other Expenses0.00%
Total Expenses0.45%
Fee Waiver0.00%
Net Expenses0.45%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker

speech bubbles
speech bubbles











WisdomTree Brazilian Real Strategy Fund (NYSEARCA:BZF) Frequently Asked Questions

What stocks does MarketBeat like better than WisdomTree Brazilian Real Strategy Fund?

Wall Street analysts have given WisdomTree Brazilian Real Strategy Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but WisdomTree Brazilian Real Strategy Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has WisdomTree Brazilian Real Strategy Fund's stock been impacted by COVID-19?

WisdomTree Brazilian Real Strategy Fund's stock was trading at $16.4601 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BZF shares have increased by 0.0% and is now trading at $16.4601.
View which stocks have been most impacted by COVID-19
.

Is WisdomTree Brazilian Real Strategy Fund a good dividend stock?

WisdomTree Brazilian Real Strategy Fund pays an annual dividend of $0.20 per share and currently has a dividend yield of 1.19%.
View WisdomTree Brazilian Real Strategy Fund's dividend history.

What other stocks do shareholders of WisdomTree Brazilian Real Strategy Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other WisdomTree Brazilian Real Strategy Fund investors own include FOX (FOXA), General Electric (GE), Gilead Sciences (GILD), Barrick Gold (GOLD), Alphabet (GOOG), AT&T (T), Adobe (ADBE), Aurora Cannabis (ACB), Allergan (AGN) and Alexion Pharmaceuticals (ALXN).

What is WisdomTree Brazilian Real Strategy Fund's stock symbol?

WisdomTree Brazilian Real Strategy Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BZF."

How do I buy shares of WisdomTree Brazilian Real Strategy Fund?

Shares of BZF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is WisdomTree Brazilian Real Strategy Fund's stock price today?

One share of BZF stock can currently be purchased for approximately $16.46.

How much money does WisdomTree Brazilian Real Strategy Fund make?

WisdomTree Brazilian Real Strategy Fund has a market capitalization of $12.35 million.


This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.